Practice Locations
2401 Ravine Way
Suite 300
Glenview, IL 60025- Phone: 847-998-5680
- Fax: 847-998-6365
Affiliated Hospitals
- Evanston Hospital - NorthShore University Health System
- Glenbrook Hospital - NorthShore University Health System
- Highland Park Hospital - NorthShore University Health System
- Skokie Hospital - NorthShore University Health System
Areas of Expertise
- Rheumatoid Arthritis
- Osteoporosis/Osteopenia
- Osteoarthritis
- Gout/Pseudogout
- Psoriatic Arthritis
- Ankylosing Spondylitis
- Lupus and Autoimmune Disorders
- Polymyalgia Rheumatica
- Sjogren’s Syndrome
- Mixed Connective Tissue Disease
- Dermatomyositis/Polymyositis
- Vasculitis
- Scleroderma
- Joint Pain
- PRP Injections
Biography
Dr. Alfonso Bello is a board-certified rheumatologist with an additional board certification in pain medicine. He provides care for arthritis, osteoporosis and inflammatory diseases. Dr. Bello provides advanced treatments, including the latest forms of chemotherapy, immunotherapy and biologic therapies. He puts particular emphasis on strategies to control patients’ pain, whatever the cause may be. He takes a holistic approach that combines medication with physical therapy, nutritional therapy and other treatments. His goal is to put patients’ illnesses into remission and to restore their quality of life.
Dr. Bello is the director of rheumatologic research at IBJI. He and his fellow IBJI rheumatologists are conducting multiple clinical trials of new medications, providing patients with the opportunity to take part in these studies and be treated with promising new therapies.
He is an expert in osteoarthritis treatment guidelines and lectures internationally to physician and pharmaceutical industry groups. Dr. Bello is also a former commander in the U.S. Public Health Service assigned to the U.S. Coast Guard.
Education
Medical School
University of Illinois, College of Medicine - Doctor of Medicine (MD)
Internship
Advocate Lutheran General Hospital - Medicine
Residency
Lutheran General Hospital - Internal Medicine
Fellowship
Duke University Medical Center, Durham NC - Rheumatology
- Bello AE, Oesser S. Collagen hydrolysate for the treatment of osteoarthritisand other joint disorders: a review of the literature. Curr Med Res Opin. 2006Nov;22(11):2221-32. doi: 10.1185/030079906X148373. PMID: 17076983.
- Bello AE, Holt RJ. Cardiovascular risk with non-steroidal anti-inflammatorydrugs: clinical implications. Drug Saf. 2014 Nov;37(11):897-902. doi:10.1007/s40264-014-0207-2. PMID: 25079141; PMCID: PMC4206767.
- Bello AE, Perkins EL, Jay R, Efthimiou P. Recommendations for optimizingmethotrexate treatment for patients with rheumatoid arthritis. Open AccessRheumatol. 2017 Mar 31;9:67-79. doi: 10.2147/OARRR.S131668. PMID: 28435338;PMCID: PMC5386601.
- Francis-Sedlak M, LaMoreaux B, Padnick-Silver L, Holt RJ, Bello AE.Characteristics, Comorbidities, and Potential Consequences of Uncontrolled Gout:An Insurance-Claims Database Study. Rheumatol Ther. 2021 Mar;8(1):183-197. doi:10.1007/s40744-020-00260-1. Epub 2020 Dec 7. PMID: 33284422; PMCID:PMC7991061.
- Bello AE, Kent JD, Holt RJ. Gastroprotective efficacy and safety of single-tablet ibuprofen/famotidine vs ibuprofen in older persons. Phys Sportsmed. 2015Jul;43(3):193-9. doi: 10.1080/00913847.2015.1066229. Epub 2015 Jul 13. PMID:26165391.
- Singh G, Fort JG, Goldstein JL, Levy RA, Hanrahan PS, Bello AE, Andrade-Ortega L, Wallemark C, Agrawal NM, Eisen GM, Stenson WF, Triadafilopoulos G;SUCCESS-I Investigators. Celecoxib versus naproxen and diclofenac inosteoarthritis patients: SUCCESS-I Study. Am J Med. 2006 Mar;119(3):255-66. doi:10.1016/j.amjmed.2005.09.054. Erratum in: Am J Med. 2006 Sep;119(9):801. PMID:16490472.
- Bello AE, Kent JD, Grahn AY, Ball J, Holt RJ. One-year open-label safetyevaluation of the fixed combination of ibuprofen and famotidine with aprospective analysis of dyspepsia. Curr Med Res Opin. 2015 Mar;31(3):397-405.doi: 10.1185/03007995.2014.999152. Epub 2015 Jan 9. PMID: 25495134.
- Laine L, Kivitz AJ, Bello AE, Grahn AY, Schiff MH, Taha AS. Double-blindrandomized trials of single-tablet ibuprofen/high-dose famotidine vs. ibuprofenalone for reduction of gastric and duodenal ulcers. Am J Gastroenterol. 2012Mar;107(3):379-86. doi: 10.1038/ajg.2011.443. Epub 2011 Dec 20. PMID: 22186979;PMCID: PMC3321505.
- Ekman EF, Gimbel JS, Bello AE, Smith MD, Keller DS, Annis KM, Brown MT, WestCR, Verburg KM. Efficacy and safety of intravenous tanezumab for the symptomatictreatment of osteoarthritis: 2 randomized controlled trials versus naproxen. JRheumatol. 2014 Nov;41(11):2249-59. doi: 10.3899/jrheum.131294. Epub 2014 Oct 1.PMID: 25274899.
- Bello AE, Grahn AY, Ball J, Kent JD, Holt RJ. One-year safety ofibuprofen/famotidine fixed combination versus ibuprofen alone: pooled analysesof two 24-week randomized, double-blind trials and a follow-on extension. CurrMed Res Opin. 2015 Mar;31(3):407-20. doi: 10.1185/03007995.2014.1000086. Epub2015 Jan 12. PMID: 25516006.
- Tive L, Bello AE, Radin D, Schnitzer TJ, Nguyen H, Brown MT, West CR. Pooledanalysis of tanezumab efficacy and safety with subgroup analyses of phase IIIclinical trials in patients with osteoarthritis pain of the knee or hip. J PainRes. 2019 Mar 19;12:975-995. doi: 10.2147/JPR.S191297. Erratum in: J Pain Res.2020 Sep 14;13:2267-2268. doi: 10.2147/JPR.S279856. PMID: 30936738; PMCID:PMC6430070.
- Goldstein JL, Bello AE, Spalding W, Suh S, Fort JG. Cyclooxygenase-2specific inhibitors and upper gastrointestinal tolerability in patients withosteoarthritis receiving concomitant low dose aspirin: pooled analysis of 2trials. J Rheumatol. 2005 Jan;32(1):111-7. PMID: 15630735.
- Whelton A, White WB, Bello AE, Puma JA, Fort JG; SUCCESS-VII Investigators.Effects of celecoxib and rofecoxib on blood pressure and edema in patients > or=65 years of age with systemic hypertension and osteoarthritis. Am J Cardiol.2002 Nov 1;90(9):959-63. doi: 10.1016/s0002-9149(02)02661-9. PMID: 12398962.
- Holt RJ, Fort JG, Grahn AY, Kent JD, Bello AE. Onset and durability of painrelief in knee osteoarthritis: Pooled results from two placebo trials ofnaproxen/esomeprazole combination and celecoxib. Phys Sportsmed. 2015Jul;43(3):200-12. doi: 10.1080/00913847.2015.1074852. Epub 2015 Aug 3. PMID:26313454.
- Bello AE, Kent JD, Grahn AY, Rice P, Holt RJ. Risk of upper gastrointestinal ulcers in patients with osteoarthritis receiving single-tablet ibuprofen/famotidine versus ibuprofen alone: pooled efficacy and safety analyses of two randomized, double-blind, comparison trials. Postgrad Med. 2014 Jul;126(4):82-91. doi: 10.3810/pgm.2014.07.2786. PMID: 25141246.
- Bello AE. DUEXIS(®) (ibuprofen 800 mg, famotidine 26.6 mg): a new approachto gastroprotection for patients with chronic pain and inflammation who requiretreatment with a nonsteroidal anti-inflammatory drug. Ther Adv MusculoskeletDis. 2012 Oct;4(5):327-39. doi: 10.1177/1759720X12444710. PMID: 23024710;PMCID:PMC3458616.
- American College of Rheumatology Pain Management Task Force. Report of theAmerican College of Rheumatology Pain Management Task Force. Arthritis Care Res(Hoboken). 2010 May;62(5):590-9. doi: 10.1002/acr.20005. PMID: 20461782.
- Holt RJ, Fort JG, Grahn AY, Kent JD, Bello AE. Onset and durability of painrelief in knee osteoarthritis: pooled results from two placebo trials ofnaproxen/esomeprazole combination and celecoxib. Phys Sportsmed. 2015 Aug3:1-13. Epub ahead of print. PMID: 26235613.
- Patterson R, Bello AE, Lefkowith J. Immunologic tolerability profile ofcelecoxib. Clin Ther. 1999 Dec;21(12):2065-79. doi:10.1016/s0149-2918(00)87238-0. PMID: 10645754.
- Bello AE, Garrett WE Jr, Wang H, Lohnes J, DeLong E, Caterson B, Kraus VB.Comparison of synovial fluid cartilage marker concentrations and chondral damageassessed arthroscopically in acute knee injury. Osteoarthritis Cartilage. 1997Nov;5(6):419-26. doi: 10.1016/s1063-4584(97)80046-5. PMID: 9536290.
- Cajigas Melgoza, Juan Carlos; Ariza Andraca, Raúl; Espinosa Morales, Rolando;Méndez Medina, Carlos; Mirassou Ortega, Manuel; Robles San Román, Manuel;Santillán Barrera, Ernesto; Trillo Aparicio, Gabriela Ivonne; Ventura Ríos, Luicio; WaissSkvirsky, Sharon; Bello, Alfonso E.; Velasco, Jorge Aldrete; Cantú Ruiz, Ana Teresa.Guía de práctica clínica basada en la evidencia para el diagnóstico y tratamiento de laosteoarthritis. Medicina Interna de Mexico, 2011, Vol 27, Issue 6, p552.
- Puma JA, Bello AE, Rodriguez JJ, Fort JG. The effects of COX-2 specific inhibitorson edema and systolic blood pressure in elderly patients with osteoarthritis and treatedhypertension: a pooled analysis on 1,902 patients. American Journal of Hypertension,Volume 15, Issue S3, April 2002, Page 118A.https://doi.org/10.1016/S0895-7061(02)02595-5
- Megan Francis-Sedlak, Brian LaMoreaux, Lissa Padnick-Silver, Robert J. Holt, Alfonso E. Bello. Characteristics, Comorbidities, and Potential Consequences of Uncontrolled Gout: An Insurance Claims Database Study. November 16, 2020
- Fellow, American College of Physicians
- Fellow, American College of Rheumatology
- American College of Rheumatology Scholar Award
- American College of Rheumatology Traveling Student Award
- University of Chicago Distinguished Resident Teaching Award
- Clinical Associate Professor of Medicine,University of Illinois College of Medicine, Chicago IL
- Adjunct Associate Professor of Family Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL; 2007 -2009
- Consulting Associate, Duke University Medical Center, Division of Rheumatology, Allergy and Clinical Immunology, Durham NC
- Director of Clinical Research, IBJI Rheumatology
- Former Chief, Section of Rheumatology, Department of Internal Medicine, Advocate Illinois Masonic Medical Center, Chicago IL
- Chief Medical Officer, Integrated Medical Affairs, Inc., Glenview IL
View Dr. Bello's Media
IBJI Dr. Bello & Rheumatic Disease
Dr. Bello as heard on WGN radio
Dr. Bello as heard on WGN radio
Dr. Bello Introduction
Patient Feedback
Want to share your patient story for Dr. Bello? Complete this form.
“Very helpful with arthritis pain.”
“Dr. Bello is an excellent caring physician devoted to finding the best care for patients facing the ongoing complexity and challenges of autoimmune diseases.”
“Dr. Bello is an excellent physician.”
“Dr. Bello is a terrific physician. I recommend him every chance I get.”